The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- UnitedHealth CEO suddenly steps down for ‘personal reasons’ (NBC News)
- Unlocking the Trillion-Dollar Future of Gastroenterology
- Listening to Patients: The Most Radical Innovation in GI?(A Candid Conversation with Dr. Neil Parikh)
- Roche launches fibrosis blood test for gauging liver disease severity (Fierce Healthcare)
- Updated Guidelines Aim to Improve GERD Diagnosis and Treatment (AJMC)
- The All New WHOOP: The World’s Most Powerful Health Wearable (Forbes)
- Priority Health launches new digestive health solution in partnership with Ayble Health (Priority Health)
- Weighing the Environmental Impact of Colorectal Cancer Screening Methods (ReachMD)